Short Interest in Crescent Capital BDC, Inc. (NASDAQ:CCAP) Decreases By 33.0%

Crescent Capital BDC, Inc. (NASDAQ:CCAP) was the recipient of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 75,600 shares, a decline of 33.0% from the November 15th total of 112,800 shares. Based on an average daily volume of 105,700 shares, the days-to-cover ratio is presently 0.7 days.

Institutional Trading of Crescent Capital BDC

Several institutional investors have recently bought and sold shares of the business. Point72 Asset Management L.P. purchased a new position in shares of Crescent Capital BDC during the 2nd quarter valued at approximately $90,000. XTX Topco Ltd acquired a new stake in shares of Crescent Capital BDC in the second quarter valued at about $195,000. Catalina Capital Group LLC purchased a new stake in shares of Crescent Capital BDC during the second quarter worth about $220,000. Cubist Systematic Strategies LLC acquired a new position in shares of Crescent Capital BDC during the 2nd quarter worth about $346,000. Finally, Van ECK Associates Corp lifted its stake in Crescent Capital BDC by 136.1% in the 2nd quarter. Van ECK Associates Corp now owns 26,521 shares of the company’s stock valued at $498,000 after buying an additional 15,288 shares in the last quarter. 49.46% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CCAP shares. LADENBURG THALM/SH SH initiated coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 price target on the stock. Keefe, Bruyette & Woods increased their price target on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. Finally, Bank of America reduced their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 15th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $19.17.

Crescent Capital BDC Price Performance

Shares of Crescent Capital BDC stock traded up $0.07 during trading hours on Friday, reaching $19.98. The stock had a trading volume of 1,451 shares, compared to its average volume of 128,901. Crescent Capital BDC has a twelve month low of $15.91 and a twelve month high of $20.01. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14. The firm has a market capitalization of $740.46 million, a PE ratio of 7.81 and a beta of 0.82. The stock’s 50 day moving average is $18.76 and its 200 day moving average is $18.63.

Crescent Capital BDC Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.42 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $1.68 dividend on an annualized basis and a yield of 8.41%. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio is currently 65.88%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.